Satudora Holdings Co.,Ltd.
Satudora Holdings Co.,Ltd. 3544.T Peers
See (3544.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 3544.T | $848.00 | +0.83% | 11.67B | 19.19 | $44.20 | +1.18% |
| 3088.T | $2,947.50 | +0.36% | 1.19T | 22.04 | $133.74 | +1.49% |
| 3349.T | $9,063.00 | +0.57% | 718.31B | 24.42 | $371.18 | +0.69% |
| 3391.T | $11,610.00 | +1.18% | 565.14B | 34.56 | $335.93 | +2.30% |
| 7649.T | $3,072.00 | +0.07% | 555.93B | 21.64 | $141.98 | +1.14% |
| 9989.T | $4,505.00 | -0.53% | 526.94B | 17.45 | $258.20 | +2.89% |
| 3141.T | $2,501.00 | +1.05% | 519.17B | 34.65 | $72.18 | +1.44% |
| 3549.T | $3,497.00 | +0.95% | 359.31B | 19.88 | $175.91 | +0.40% |
| 3148.T | $3,130.00 | +0.32% | 202.21B | 14.26 | $219.44 | +2.27% |
| 9627.T | $5,464.00 | +1.45% | 191.57B | 19.08 | $286.33 | +1.46% |
Stock Comparison
3544.T vs 3088.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 3088.T has a market cap of 1.19T. Regarding current trading prices, 3544.T is priced at $848.00, while 3088.T trades at $2,947.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 3088.T's P/E ratio is 22.04. In terms of profitability, 3544.T's ROE is +0.07%, compared to 3088.T's ROE of +0.10%. Regarding short-term risk, 3544.T is less volatile compared to 3088.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 3349.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 3349.T has a market cap of 718.31B. Regarding current trading prices, 3544.T is priced at $848.00, while 3349.T trades at $9,063.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 3349.T's P/E ratio is 24.42. In terms of profitability, 3544.T's ROE is +0.07%, compared to 3349.T's ROE of +0.12%. Regarding short-term risk, 3544.T is less volatile compared to 3349.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 3391.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 3391.T has a market cap of 565.14B. Regarding current trading prices, 3544.T is priced at $848.00, while 3391.T trades at $11,610.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 3391.T's P/E ratio is 34.56. In terms of profitability, 3544.T's ROE is +0.07%, compared to 3391.T's ROE of +0.06%. Regarding short-term risk, 3544.T is less volatile compared to 3391.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 7649.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 7649.T has a market cap of 555.93B. Regarding current trading prices, 3544.T is priced at $848.00, while 7649.T trades at $3,072.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 7649.T's P/E ratio is 21.64. In terms of profitability, 3544.T's ROE is +0.07%, compared to 7649.T's ROE of +0.11%. Regarding short-term risk, 3544.T is less volatile compared to 7649.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 9989.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 9989.T has a market cap of 526.94B. Regarding current trading prices, 3544.T is priced at $848.00, while 9989.T trades at $4,505.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 9989.T's P/E ratio is 17.45. In terms of profitability, 3544.T's ROE is +0.07%, compared to 9989.T's ROE of +0.12%. Regarding short-term risk, 3544.T is less volatile compared to 9989.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 3141.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 3141.T has a market cap of 519.17B. Regarding current trading prices, 3544.T is priced at $848.00, while 3141.T trades at $2,501.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 3141.T's P/E ratio is 34.65. In terms of profitability, 3544.T's ROE is +0.07%, compared to 3141.T's ROE of +0.06%. Regarding short-term risk, 3544.T is less volatile compared to 3141.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 3549.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 3549.T has a market cap of 359.31B. Regarding current trading prices, 3544.T is priced at $848.00, while 3549.T trades at $3,497.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 3549.T's P/E ratio is 19.88. In terms of profitability, 3544.T's ROE is +0.07%, compared to 3549.T's ROE of +0.13%. Regarding short-term risk, 3544.T is less volatile compared to 3549.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 3148.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 3148.T has a market cap of 202.21B. Regarding current trading prices, 3544.T is priced at $848.00, while 3148.T trades at $3,130.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 3148.T's P/E ratio is 14.26. In terms of profitability, 3544.T's ROE is +0.07%, compared to 3148.T's ROE of +0.11%. Regarding short-term risk, 3544.T is less volatile compared to 3148.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 9627.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 9627.T has a market cap of 191.57B. Regarding current trading prices, 3544.T is priced at $848.00, while 9627.T trades at $5,464.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 9627.T's P/E ratio is 19.08. In terms of profitability, 3544.T's ROE is +0.07%, compared to 9627.T's ROE of +0.07%. Regarding short-term risk, 3544.T is less volatile compared to 9627.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 9267.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 9267.T has a market cap of 106.54B. Regarding current trading prices, 3544.T is priced at $848.00, while 9267.T trades at $3,505.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 9267.T's P/E ratio is 15.82. In terms of profitability, 3544.T's ROE is +0.07%, compared to 9267.T's ROE of +0.14%. Regarding short-term risk, 3544.T is less volatile compared to 9267.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 3341.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 3341.T has a market cap of 94.70B. Regarding current trading prices, 3544.T is priced at $848.00, while 3341.T trades at $3,170.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 3341.T's P/E ratio is 68.26. In terms of profitability, 3544.T's ROE is +0.07%, compared to 3341.T's ROE of +0.02%. Regarding short-term risk, 3544.T is less volatile compared to 3341.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 3034.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 3034.T has a market cap of 67.90B. Regarding current trading prices, 3544.T is priced at $848.00, while 3034.T trades at $1,808.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 3034.T's P/E ratio is 16.04. In terms of profitability, 3544.T's ROE is +0.07%, compared to 3034.T's ROE of +0.09%. Regarding short-term risk, 3544.T is less volatile compared to 3034.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 2664.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 2664.T has a market cap of 62.51B. Regarding current trading prices, 3544.T is priced at $848.00, while 2664.T trades at $2,799.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 2664.T's P/E ratio is 14.29. In terms of profitability, 3544.T's ROE is +0.07%, compared to 2664.T's ROE of +0.04%. Regarding short-term risk, 3544.T is less volatile compared to 2664.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 219A.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 219A.T has a market cap of 56.45B. Regarding current trading prices, 3544.T is priced at $848.00, while 219A.T trades at $2,501.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 219A.T's P/E ratio is -50.72. In terms of profitability, 3544.T's ROE is +0.07%, compared to 219A.T's ROE of -0.10%. Regarding short-term risk, 3544.T is less volatile compared to 219A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 4931.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 4931.T has a market cap of 46.26B. Regarding current trading prices, 3544.T is priced at $848.00, while 4931.T trades at $2,189.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 4931.T's P/E ratio is 20.18. In terms of profitability, 3544.T's ROE is +0.07%, compared to 4931.T's ROE of +0.14%. Regarding short-term risk, 3544.T is less volatile compared to 4931.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 7679.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 7679.T has a market cap of 39.76B. Regarding current trading prices, 3544.T is priced at $848.00, while 7679.T trades at $2,029.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 7679.T's P/E ratio is 10.21. In terms of profitability, 3544.T's ROE is +0.07%, compared to 7679.T's ROE of +0.12%. Regarding short-term risk, 3544.T is less volatile compared to 7679.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 8095.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 8095.T has a market cap of 18.77B. Regarding current trading prices, 3544.T is priced at $848.00, while 8095.T trades at $465.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 8095.T's P/E ratio is -7.36. In terms of profitability, 3544.T's ROE is +0.07%, compared to 8095.T's ROE of -0.08%. Regarding short-term risk, 3544.T is less volatile compared to 8095.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 3417.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 3417.T has a market cap of 14.76B. Regarding current trading prices, 3544.T is priced at $848.00, while 3417.T trades at $1,082.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 3417.T's P/E ratio is 7.95. In terms of profitability, 3544.T's ROE is +0.07%, compared to 3417.T's ROE of +0.08%. Regarding short-term risk, 3544.T is less volatile compared to 3417.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 4350.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 4350.T has a market cap of 12.98B. Regarding current trading prices, 3544.T is priced at $848.00, while 4350.T trades at $444.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 4350.T's P/E ratio is 10.27. In terms of profitability, 3544.T's ROE is +0.07%, compared to 4350.T's ROE of +0.10%. Regarding short-term risk, 3544.T is less volatile compared to 4350.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 4890.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 4890.T has a market cap of 9.85B. Regarding current trading prices, 3544.T is priced at $848.00, while 4890.T trades at $384.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 4890.T's P/E ratio is 48.42. In terms of profitability, 3544.T's ROE is +0.07%, compared to 4890.T's ROE of +0.29%. Regarding short-term risk, 3544.T is less volatile compared to 4890.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.
3544.T vs 2796.T Comparison
3544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3544.T stands at 11.67B. In comparison, 2796.T has a market cap of 5.54B. Regarding current trading prices, 3544.T is priced at $848.00, while 2796.T trades at $488.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3544.T currently has a P/E ratio of 19.19, whereas 2796.T's P/E ratio is -6.80. In terms of profitability, 3544.T's ROE is +0.07%, compared to 2796.T's ROE of -0.11%. Regarding short-term risk, 3544.T is less volatile compared to 2796.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3544.T.